Henry Crown and Company’s investment affiliate CVF returned once again to back an $85m round for root canal treatment developer Sonendo.

Today’s deal net captures the smaller investments from across the university innovation ecosystem over the past two weeks.

Chinese Academy of Sciences-owned Cash Capital was among the investors in precision cancer screening business MyGene Diagnostics' second funding round.

GV-backed One Medical owner 1Life has filed to go public, setting a placeholder target of $100m, having raised $400m in equity financing.

The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.

Pieces Technology, a medical intelligence technology provider that counts OSF Healthcare and Children’s Health among its investors, has secured $25.7m.

The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.

In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.

The Legend Capital-backed radiology-imaging technology provider received $23m in a series B round led by Sherpa Venture Capital.

Bic Camera, Brother Industries, Hi-Lex, Nac, TIS, Tokai and Towa were among the backers that supplied $32.3m for TUS spinout Innophys' series C funding.